Antonella Savio

Learn More
BACKGROUND Hepatocellular carcinoma is one of the leading causes of death for compensated chronic liver disease. AIM The evaluation of technical success as primary ablation rate, local tumor progression, safety, and long--term patients outcome of radiofrequency ablation in single (less than 3.5 cm in diameter) or multiple nodules (up to 3, sized less than(More)
  • 1